| Alrex (U.S.N.L.M.) | |
|---|---|
| Dosing | 1 drop qid |
| Chem Specs | loteprednol etabonate 0.2% |
| Quantities | 5ml, 10ml |
| Cost | 305.00/5ml Increased IOP is more likely with FML but costs much less. |
| Class | Ester based "soft" steroid suspension |
| Action | Anti-inflammatory |
| Usage | Indicated for the temporary relief of seasonal allergic conjunctivitis. |
| Used off label for inflammatory dry eye and as a brief initial adjunctive with Restasis. Used off label to reduce inflammatory sequelae of EKC. |
|
| Contraindications | Most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis, vaccinia, and varicella, mycobacterial and fungal disease. Hypersensitivity to any of the ingredients of this preparation and to other corticosteroids. |
| Pediatric use | Safety and effectiveness in pediatric patients have not been established. |
| Pregnancy | Embryotoxic and teratogenic for rabbits at 85x the maximum daily clinical dose but not at 15x. |
| BAK preserved (0.01%). Contains glycerin moisturizer. Should not be used to treat contact lens related irritation. Lotemax is the 0.5% preparation of loteprednol etabonate |